Загрузка...
Developing the Totality of Evidence for Biosimilars: Regulatory Considerations and Building Confidence for the Healthcare Community
Biosimilars are highly similar versions of approved branded biologics. Unlike generics, they are not exact replicas of reference products. Minor differences between biosimilars and reference products in some aspects are expected; likewise, biosimilar products will differ from each other. The objecti...
Сохранить в:
| Опубликовано в: : | BioDrugs |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer International Publishing
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5443883/ https://ncbi.nlm.nih.gov/pubmed/28439817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-017-0218-5 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|